AMGN vs VCEL · P/E 24, rev $36.75B vs P/E 835, rev $237.2M
Amgen Inc (AMGN) versus Vericel Corp Ord (VCEL) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Vericel Corp Ord (VCEL) is a biotechnology company listed on US.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported VCEL revenue for 2024-12-31 was $237.2M. Net income was $10.4M. Revenue was up 20.1% from 2023-12-31 to 2024-12-31. VCEL currently screens at market cap $2.10B and trailing P/E 834.8.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. VCEL currently screens at market cap $2.10B and trailing P/E 834.8.
Not investment advice. Open the AMGN and VCEL stock pages for the full models.
Not investment advice.